financetom
Business
financetom
/
Business
/
Abercrombie & Fitch to Be Official NFL Fashion Partner
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Abercrombie & Fitch to Be Official NFL Fashion Partner
Aug 25, 2025 4:34 AM

07:06 AM EDT, 08/25/2025 (MT Newswires) -- Abercrombie & Fitch ( ANF ) said Monday it has entered into a multi-year partnership with National Football League as an Official NFL Fashion Partner.

The company said it will bring custom styling for NFL athletes, player-designed apparel and on-site event activations to the NFL.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Live Nation posts higher third-quarter revenue on strong fan demand
Live Nation posts higher third-quarter revenue on strong fan demand
Nov 4, 2025
Nov 4 (Reuters) - Ticketmaster-parent Live Nation reported a rise in third-quarter revenue on Tuesday, helped by demand for concerts and festivals. Fans are spending on immersive live entertainment despite economic headwinds, benefiting Live Nation, which is a bellwether for discretionary spending across the entertainment industry. Strong fan demand drove another record quarter, as we continue to attract more fans...
Crexendo Q3 revenue beats estimates on strength in software solutions business
Crexendo Q3 revenue beats estimates on strength in software solutions business
Nov 4, 2025
Overview * Crexendo Q3 2025 revenue grows 12% yr/yr, beating analyst expectations * Adjusted net income for Q3 2025 beats analyst estimates, reflecting strong operational performance * Software solutions revenue grows 28%, highlighting platform strength Outlook * Crexendo ( CXDO ) did not provide specific future financial guidance in the statement Result Drivers * SOFTWARE SOLUTIONS GROWTH - 28% increase...
Soleno Therapeutics posts Q3 profit on strong VYKAT XR sales 
Soleno Therapeutics posts Q3 profit on strong VYKAT XR sales 
Nov 4, 2025
Overview * Soleno Q3 net income at $26 mln, achieving profitability with VYKAT XR sales * VYKAT XR sales reach $66 mln in Q3, more than doubling from previous quarter * Company raised $230 mln through stock offering, strengthening financial position Outlook * Soleno expects selling, general and administrative expenses to rise post-VYKAT XR commercialization Result Drivers * VYKAT XR...
Day One Biopharmaceuticals Q3 revenue beats estimates on OJEMDA strength
Day One Biopharmaceuticals Q3 revenue beats estimates on OJEMDA strength
Nov 4, 2025
Overview * Day One Q3 revenue of $39.8 mln beats analyst expectations * OJEMDA net product revenue rises 15% from Q2, driven by higher patient demand * Company raises full-year 2025 OJEMDA revenue guidance to $145-$150 mln Outlook * Company raises OJEMDA full-year 2025 revenue guidance to $145-$150 mln Result Drivers * INCREASED DEMAND - OJEMDA net product revenue rose...
Copyright 2023-2026 - www.financetom.com All Rights Reserved